Trials / Completed
CompletedNCT04343339
Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment
Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment - EPILOGUE
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- University Hospital, Montpellier · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The current containment linked to COVID-19 will have consequences for people suffering from addiction and there is a risk of overdoses when the containment ends. So the investigators hypothesize that this health crisis is an opportunity to develop risk reduction and access to care for vulnerable people who lives with an addiction. The main objective of this study is to describe the changes in the psychoactive substances consumption during the containment in people suffering from addiction. The secondary objectives are to describe the evolution at 1 month from the end of the containment of problematic consumption and the level of access to care of these users
Conditions
Timeline
- Start date
- 2020-04-08
- Primary completion
- 2020-07-30
- Completion
- 2020-09-30
- First posted
- 2020-04-13
- Last updated
- 2020-10-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04343339. Inclusion in this directory is not an endorsement.